Clinical Trials Arena on MSN

GSK to file for approval of twice-yearly hep B drug on positive Phase III data

GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.
FiercePharma

GSK plant wins energy award; Indian court backs J&J license revocation; France's ANSM clears Teva plant in packaging switch;

> Federal authorities want to seize 3,200 cases of products held in a warehouse by GNC, the country's largest supplement seller, saying they contain the stimulant dimethylamylamine, which the FDA in ...
Insurancenewsnet.com

Recent Findings in Meningococcal Described by Researchers from GlaxoSmithKline plc (Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease In France: a ...

2021 JUL 29 (NewsRx) -- By a News Reporter-Staff News Editor at Information Technology Business Daily-- Current study results on Meningococcal have been published. According to news reporting from ...